3-Hydroxy Steroids with Lewis and Anhydrous Protic Acids
Procedure B
0.99 (d, J = 6.2 Hz, 3H, 21-CH3), 0.86 (s, 3H, 19-CH3), 0.73 (s, 3H, 18-
Pregn-4-en-3b,17a,20b-triol (1; 1.0 g, 3.0 mmol) was dissolved in dry
1,4-dioxane (120 mL), and aluminum trichloride (1.2 g, 9.0 mmol) was
added. The resulting solution was refluxed under stirring until TLC
analysis (chloroform ⁄ methanol, 20:1) showed the complete consump-
tion of the precursor. The organic solvent was removed under vac-
uum, and the residue was treated with distilled water (30 mL), then
extracted with ethyl acetate (3 · 50 mL). The combined organic lay-
ers were washed once with brine (30 mL), dried over Na2SO4, fil-
tered, and evaporated to dryness under vacuum. The crude solid
residue was purified by flash column chromatography (chloro-
form ⁄ methanol, 20:1) to afford 0.8 g (84%) of 2 as pure product.
Compound 2 obtained by this procedure showed physicochemical
properties, and NMR spectra identical to those observed for a sam-
ple of the same compound prepared by applying the procedure A.
CH3); 13C NMR (DEPT, 75 MHz, DMSO-d6) d 14.6 (CH3), 16.8 (CH3),
18.9 (CH3), 21.0 (CH2), 23.8 (CH2), 31.0 (CH2), 31.6 (CH2), 32.0 (CH2),
33.8 (CH2), 36.2 (CH), 37.0 (C), 37.9 (CH2), 46.9 (C), 49.5 (CH), 54.7
(CH), 69.5 (CH), 84.6 (C), 117.2 (CH), 122.9 (CH), 123.3 (CH), 145.8 (C).
Treatment of pregn-4-en-3b,17a,20b-triol (1)
with titanium tetrachloride
A 1 M dichloromethane solution of titanium tetrachloride (5.4 mL,
5.4 mmol) was added to a suspension of pregn-4-en-3b,17a,20b-
triol (1; 0.6 g, 1.8 mmol) in dry dichloromethane (40 mL). The mix-
ture was maintained under magnetic stirring for 20 min at room
temperature, until TLC analysis of the reaction mixture (chloro-
form ⁄ methanol 20:1 v ⁄ v) showed complete consumption of the pre-
cursor. The organic solvent was removed under vacuum, and the
residue was treated with distilled water (25 mL), then extracted
with ethyl acetate (3 · 25 mL). The combined organic layers were
washed once with brine (25 mL), dried over Na2SO4, filtered, and
evaporated to dryness under vacuum. The crude solid residue was
purified by flash column chromatography (chloroform ⁄ methanol 20:1
v ⁄ v) to afford 0.52 g (89%) of 2 as pure compound. 1H and 13C
NMR spectra recorded for a sample of the pure product obtained
after chromatography showed spectroscopic characteristics equal to
those obtained for the same compound prepared by the procedure
A, as previously described.
Pregn-3,5-dien-17a,20b-diol (2)
White solid. M.p. 139)141 ꢀC; Rf 0.37 (chloroform ⁄ methanol 20:1
1
v ⁄ v). H NMR (300 MHz, DMSO-d6,): d 5.89 (d, J = 9.7 Hz, 1H, 4-
H), 5.57 (m, 1H, 6-H), 5.35 (m, 1H, 3-H), 4.04 (d, J = 6.8 Hz, 1H, 20-
OH), 3.74 (m, 1H, 20-H), 3.42 (s, 1H, 17-OH), 1.98)2.21 (m, 3H),
1.03)1.81 (m, 14H), 1.01 (d, J = 6.2 Hz, 3H, 21-CH3), 0.89 (s, 3H,
19-CH3), 0.75 (s, 3H, 18-CH3); 13C NMR (DEPT, 75 MHz, DMSO-d6) d
14.7 (CH3), 18.7 (CH3), 18.9 (CH3), 20.3 (CH2), 22.7 (CH2), 23.7 (CH2),
31.6 (CH), 31.7 (CH2), 31.8 (CH2), 33.4 (CH2), 33.8 (CH2), 34.7 (C),
46.9 (C), 47.6 (CH), 50.4 (CH), 69.5 (CH), 84.7 (C), 123.1 (CH), 124.7
(CH), 129.1 (CH), 141.0 (C). GC ⁄ MS (EI) m ⁄ z (%): 316 (43) [M+], 298
(7), 271 (43), 253 (100), 239 (3), 226 (11), 213 (63), 197 (13), 173 (8),
159 (12), 157 (17), 145 (27), 143 (24), 131 (15), 105 (34), 91 (36), 81
(38), 67 (14). Anal. Calcd. for C21H32O2: C, 79.70; H, 10.19. Found: C
79.42; H 10.22.
Treatment of pregn-4-en-3b,17a,20b-triol (1)
with CSA in toluene
A solution of 1 (120 mg, 0.36 mmol) and catalytic amounts of CSA
(8.4 mg, 0.04 mmol, 10% mol) in dry toluene were refluxed in a
Dean–Stark apparatus for 5 h. After this time, the solvent was dis-
tilled under reduced pressure and the residue was dissolved in
ethyl acetate (10 mL) and then washed once with a 5% NaHCO3
aqueous solution (10 mL). The organic layer was washed once with
brine (10 mL), dried over Na2SO4, filtered, and evaporated to dry-
ness under vacuum. The crude material was fractionated by short-
column flash chromatography (chloroform ⁄ methanol 20:1 v ⁄ v). Purifi-
cation gave 103 mg (90%) of a mixture of the epimeric dienes 2
and 3, which was subjected to the next thermal treatment, and
very small amounts (3 mg) of a second fraction (Rf = 0.88) contain-
Treatment of pregn-4-en-3b,17a,20b-triol (1)
with CSA
To a solution of pregn-4-en-3b,17a,20b-triol (1; 1.0 g, 3.0 mmol) in
dry 1,4-dioxane (50 mL), CSA (0.08 g, 0.32 mmol) was added. The
resulting mixture was refluxed under stirring for 2 h. After this
time, TLC analysis (chloroform ⁄ methanol, 20:1) showed complete
consumption of the precursor. The organic solvent was removed
under vacuum, and the residue was treated with distilled water
(30 mL), then extracted with ethyl acetate (3 · 30 mL). The com-
bined organic layers were washed once with brine (30 mL), dried
over Na2SO4, filtered, and evaporated to dryness under vacuum.
The crude solid residue was purified by chromatography (ethyl ace-
tate ⁄ petroleum ether, 50:50) to give 0.85 g (89% total yield) of a
1
ing 4, which was directly analyzed by H- and 13C NMR and by GC-
MS. The mixture of epimers 2 and 3 showed NMR data equal to
those observed for the same pair of epimers obtained by the treat-
ment of 1 with CSA in 1,4-dioxane. For compound 4, the following
main physicochemical data were determined: 1H NMR (300 MHz,
CDCl3): d 5.92 (d, J = 9.6 Hz, 1 H, 4-H), 5.60 (m, 1 H, 6-H), 5.38 (m,
1 H, 3-H), 2.48 (m, 1 H, 17-H), 2.18 (m, 3 H, 21-CH3). 13C NMR
(75 MHz, DMSO-d6, 25 ꢀC): d 209.1, 141.0, 128.8, 125.3, 122.3.
GC ⁄ MS (CI): m ⁄ z (%) 339 (8) [M+C3H5]+, 327 (12) [M+C2H5]+, 299
(100) [M+H]+, 281 (73) [(M-H2O)+H]+, 255 (33) [(M-COCH3)+H]+.
1
mixture of the two epimers 2 and 3. H NMR analysis performed
on a sample of the product obtained after chromatography indicated
an approximately 3:2 ratio of the C-17 a ⁄ b epimers. H, 13C, and
1
DEPT analyses of the same mixture allow also the complete assign-
ment of resonances for the epimer 3.
Pregn-3,5-dien-17 b,20b-diol (3)
Treatment of pregn-4-en-3b,17a,20b-triol (1)
with CSA in toluene
A mixture of epimers 2 and 3 (250 mg) recovered by chromatogra-
phy from the thermal treatment of 1 as previously described, and
1H NMR (300 MHz, DMSO-d6,): d 5.75 (m, 1H, 4-H), 5.60 (m, 1H, 6-
H), 5.46 (m, 1H, 3-H), 4.07 (d, J = 6.8 Hz, 1H, 20-OH), 3.73 (m, 1H,
20-H), 3.40 (s, 1H, 17-OH), 2.01)2.28 (m, 3H), 1.01)1.81 (m, 14H),
Chem Biol Drug Des 2011; 78: 269–276
271